Galderma Group AG (GDERF)

OTCMKTS · Delayed Price · Currency is USD
187.33
-10.08 (-5.10%)
At close: Feb 27, 2026
56.10%
Market Cap 45.05B
Revenue (ttm) 4.69B
Net Income (ttm) 378.00M
Shares Out n/a
EPS (ttm) 1.59
PE Ratio 119.17
Forward PE 45.64
Dividend 0.18 (0.09%)
Ex-Dividend Date Apr 25, 2025
Volume 91
Average Volume 973
Open 180.45
Previous Close 197.40
Day's Range 180.45 - 187.33
52-Week Range 108.10 - 213.50
Beta n/a
RSI 44.97
Earnings Date Mar 5, 2026

About Galderma Group AG

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes ACTINICA, Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, Mirvaso, NEMLUVIO, Relfydess, Benzac, Loceryl, and TRI-LUMA in therapeutic dermatology. ... [Read more]

Sector Healthcare
Founded 1981
Employees 6,545
Stock Exchange OTCMKTS
Ticker Symbol GDERF
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.